David Scadden
Vermögen: 600 319 $ am 31.05.2026
Vermögen: 600 319 $ am 31.05.2026
David T.
Scadden is the founder of Fate Therapeutics, Inc., founded in 2007.
Dr. Scadden was the founder of The Massachusetts General Hospital, founded in 2003, where the title held was Director-Hematologic Malignancies Center.
Dr. Scadden is the founder of Harvard Stem Cell Institute, founded in 2004, holding the title of Director.
Dr. Scadden was the founder of Magenta Therapeutics, Inc., founded in 2015, where the title held was Independent Director.
Dr. Scadden is also the founder of Stratus Therapeutics, Inc.,The General Hospital Corp.,Clear Creek Bio, Inc...
Dr. Scadden currently holds the position of Chairman-Emeritus & Professor at Harvard University since 2006.
Dr. Scadden is Chairman-Emeritus & Professor at Harvard Medical School.
Dr. Scadden is an Independent Director at Agios Pharmaceuticals, Inc. since 2017.
Dr. Scadden is a Director at Lightning Biotherapeutics, Inc. Dr. Scadden is an Independent Director at Editas Medicine, Inc. since 2019.
Dr. Scadden is a Director at Red Oak Medicines, Inc. Dr. Scadden is a Director at Lifevault Bio.
Dr. Scadden is a Director at Sonata Therapeutics, Inc. Dr. Scadden is an Associate Member at Massachusetts Institute of Technology.
Dr. Scadden is a Member of the American Academy of Arts & Sciences.
Dr. Scadden is a Member of the National Academy of Medicine (United States).
Dr. Scadden is an Associate Member at The Broad Institute, Inc. Former positions include Director at The International Society for Stem Cell Research.
Dr. Scadden was Independent Director at Carisma Therapeutics, Inc. from 2024 to 2025.
Dr. Scadden was Member-Scientific Counselors Board at National Cancer Institute.
Dr. Scadden was Member-External Experts Board at National Heart, Lung & Blood Institute.
Education includes undergraduate degree from Bucknell University, doctorate degrees from Case Western Reserve University and the University of Lund.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 20 419 ( 0,03 % ) | 600 319 $ | 31.05.2026 | |
| 31.05.2025 | 0 ( -.--% ) | - $ | 31.05.2026 | |
| 17.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 27.05.2017 |
| EDITAS MEDICINE, INC. | Direktor/Vorstandsmitglied | 06.02.2019 |
Lifevault Bio
Lifevault Bio Medical/Nursing ServicesHealth Services Engages in collecting and storing stem cells, DNA and blood plasma for future diagnostic and therapeutic purposes | Direktor/Vorstandsmitglied | - |
Sonata Therapeutics, Inc.
Sonata Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics and novel medicines | Direktor/Vorstandsmitglied | - |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
Red Oak Medicines, Inc.
Red Oak Medicines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Direktor/Vorstandsmitglied | - |
Clear Creek Bio, Inc.
Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nucleotide synthesis | Gründer | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 26 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
National Heart, Lung & Blood Institute
National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists | Health Technology |
The International Society for Stem Cell Research
The International Society for Stem Cell Research The International Society for Stem Cell Research (ISSCR) is a nonprofit organization dedicated to advancing stem cell science and its applications to human health. The non-profit company is based in Deerfield, IL. It represents nearly 5,000 members from over 80 countries, including scientists, educators, ethicists, clinicians, and business leaders. ISSCR promotes rigorous and ethical research through the development of international guidelines and quality standards, and provides resources such as the open-access journal Stem Cell Reports, standards documents for human stem cell use, and educational programs including annual meetings, symposia, webinars, and on-demand scientific content. The society supports workforce development by engaging early career scientists and trainees, fosters collaboration through a directory of stem cell societies and institutes, and conducts advocacy and policy efforts to provide scientific input to regulatory agencies and combat unproven stem cell therapies. ISSCR emphasizes equity, diversity, and inclusion, and offers resources for researchers, clinicians, educators, patients, and policymakers. The organization facilitates access to funding opportunities, supports continuing education, and promotes public and patient education. Membership benefits include networking, reduced fees for meetings and publishing, and access to scientific content. | |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Red Oak Medicines, Inc.
Red Oak Medicines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Clear Creek Bio, Inc.
Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nucleotide synthesis | Health Technology |
Lifevault Bio
Lifevault Bio Medical/Nursing ServicesHealth Services Engages in collecting and storing stem cells, DNA and blood plasma for future diagnostic and therapeutic purposes | Health Services |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Sonata Therapeutics, Inc.
Sonata Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics and novel medicines | Health Technology |
Carisma Therapeutics, Inc.
Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
Lightning Biotherapeutics, Inc. | Industrial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen